Tranexamic acid + Mefenamic acid + Placebo + Mirena (Levonorgestrel IUS, BAY86-5028)
ApprovedCompleted 2 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Uterine Hemorrhage
Conditions
Uterine Hemorrhage
Trial Timeline
Mar 1, 2011 → Dec 1, 2011
NCT ID
NCT01295294About Tranexamic acid + Mefenamic acid + Placebo + Mirena (Levonorgestrel IUS, BAY86-5028)
Tranexamic acid + Mefenamic acid + Placebo + Mirena (Levonorgestrel IUS, BAY86-5028) is a approved stage product being developed by Bayer for Uterine Hemorrhage. The current trial status is completed. This product is registered under clinical trial identifier NCT01295294. Target conditions include Uterine Hemorrhage.
What happened to similar drugs?
3 of 17 similar drugs in Uterine Hemorrhage were approved
Approved (3) Terminated (7) Active (8)
Hype Score Breakdown
Clinical
20
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01295294 | Approved | Completed |
Competing Products
20 competing products in Uterine Hemorrhage